Keyphrases
Clinical Outcomes
100%
Percutaneous Coronary Intervention
88%
Drug-eluting Stent
73%
Acute Myocardial Infarction
71%
Coronary Artery Spasm
68%
Hypertension
68%
Hypertensive Patients
51%
Amlodipine
46%
Korean Patients
43%
Coronary Artery Disease
41%
Acetylcholine Provocation Test
41%
Confidence Interval
40%
Randomized Double-blind
34%
Intracoronary Acetylcholine
32%
Monotherapy
31%
Hazard Ratio
31%
Losartan
30%
Blood Pressure
30%
Propensity Score Analysis
29%
Acetylcholine
28%
Arterial Stiffness
28%
Fixed-dose Combination
28%
Adverse Cardiac Events
27%
New-onset Diabetes Mellitus
27%
Myocardial Infarction Patients
26%
Myocardial Infarction
25%
Central Blood Pressure
24%
Systolic Blood Pressure
23%
Hypertensive
23%
Cardiovascular Risk
23%
Rosuvastatin
22%
Atrial Fibrillation
21%
Type 1 Diabetes Mellitus (T1DM)
21%
Statins
21%
Major Adverse Cardiovascular Events
20%
Clinical Characteristics
20%
Sirolimus-eluting Stent
20%
Asian Population
20%
Patients with Hypertension
20%
Pulse Wave Velocity
19%
Diastolic Blood Pressure
19%
Antihypertensive Drugs
19%
Cardiovascular Events
18%
High Incidence
18%
Hypertension Management
18%
Chronic Total Occlusion
18%
Atorvastatin
17%
Coronary Angiography
17%
Angiographic Characteristics
17%
Korean Population
17%
Medicine and Dentistry
Drug-Eluting Stent
73%
Percutaneous Coronary Intervention
71%
Coronary Vasospasm
61%
Acetylcholine
54%
Acute Heart Infarction
51%
Diabetes Mellitus
51%
Coronary Artery Disease
50%
Cardiovascular System
46%
Cardiovascular Disease
40%
Blood Pressure
36%
Arterial Stiffness
35%
Provocation Test
33%
Myocardial Infarction
33%
Atrial Fibrillation
30%
Coronary Artery
30%
Hazard Ratio
28%
Angina pectoris
26%
Pulse Wave Velocity
26%
Revascularization
25%
Systolic Blood Pressure
23%
Statin
23%
Rapamycin
23%
Major Adverse Cardiac Event
23%
Apoplexy
22%
Endothelial Dysfunction
20%
Multidetector Computed Tomography
20%
Ablation
19%
Left Atrium
19%
Thorax Pain
19%
Target Lesion Revascularization
17%
Paclitaxel
17%
Chronic Total Occlusion
16%
Propensity Score Matching
16%
Zotarolimus
16%
Artery
16%
Target Vessel Revascularization
14%
Coronary Angiography
14%
Cardiovascular Risk
13%
Restenosis
13%
Odds Ratio
13%
Arteriosclerosis Obliterans
13%
Muscle Spasm
13%
Myocardial Bridge
12%
Cohort Effect
12%
Diabetes
12%
Vasomotor Reflex
12%
Left Coronary Artery
12%
Percutaneous Transluminal Angioplasty
12%
Calcium Channel Blocking Agent
12%
Coronary Artery Obstruction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
59%
Coronary Artery Spasm
49%
Diabetes Mellitus
42%
Acetylcholine
38%
Amlodipine
36%
Monotherapy
34%
Heart Infarction
31%
Cardiovascular Disease
28%
Losartan
25%
Antihypertensive Agent
24%
Statin (Protein)
24%
Provocation Test
23%
Major Adverse Cardiac Event
23%
Coronary Artery Disease
23%
Atorvastatin
20%
Adverse Event
20%
Rosuvastatin
18%
Clopidogrel
17%
Combination Therapy
17%
Clinical Trial
17%
Cerebrovascular Accident
16%
ST Segment Elevation Myocardial Infarction
16%
Low Density Lipoprotein Cholesterol
15%
Cilostazol
15%
Antiplatelet
14%
Atrial Fibrillation
14%
Restenosis
13%
Endothelial Dysfunction
13%
C Reactive Protein
12%
Lipoprotein A
12%
Hypercholesterolemia
12%
Irbesartan
12%
Essential Hypertension
11%
Prevalence
11%
Acetylsalicylic Acid
11%
Rapamycin
11%
Hydrochlorothiazide
11%
Zotarolimus
11%
Angiotensin Receptor Antagonist
11%
Calcium Channel Blocker
10%
Tolerability
10%
Cardiovascular Risk
10%
Peripheral Occlusive Artery Disease
9%
Non Insulin Dependent Diabetes Mellitus
9%
Clinical Study
9%
Amlodipine Plus Telmisartan
9%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Valsartan
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Paroxysmal Atrial Fibrillation
8%